- Home
- Products
ZOLINZA (Vorinostat)
ZOLINZA (Vorinostat)
- Medicine Name: Zolinza
- Generic Name: Vorinostat
- Dosage Form & Strength: 100 mg capsules
- Manufactured By: Merck & Co., Inc.
Zolinza (vorinostat) is a histone deacetylase (HDAC) inhibitor used in the treatment of cutaneous T-cell lymphoma (CTCL). It is indicated for patients who exhibit persistent, progressive, or recurrent disease after undergoing at least two prior systemic therapies.
FDA Status:
Zolinza was approved by the U.S. FDA on October 6, 2006.
Dosage Form:
Zolinza is available in 100 mg oral capsules.
Information not available in the provided source. If available from official prescribing information, it should include guidance on:
Risk of thrombocytopenia or anemia
Potential gastrointestinal effects (e.g., nausea, vomiting, diarrhea)
Monitoring liver function and blood counts during treatment
Not recommended during pregnancy unless absolutely necessary
Caution for patients with a history of thromboembolic events
To Import Zolinza into India, the following documents are required:
- A valid prescription from a licensed oncologist
- Diagnostic reports confirming the condition
- Government-issued ID proof of the patient
Order Confirmation:
Your order will be processed only after receiving all required documents and an import permit (if applicable).
Availability in India:
Zolinza is a prescription-only medicine not typically available at retail pharmacies in India. GlobalRareMeds can assist with import under the Named Patient Program, ensuring compliance with all legal and regulatory requirements.
GlobalRareMeds sources Zolinza 100mg from certified suppliers across the United States, Canada, Europe, and Australia.
All medicines are delivered from our fulfillment center located in Ambernath, Thane District, Maharashtra. Prescriptions are verified and dispatched directly to the patient, doctor, or healthcare institution across major cities including Mumbai, Delhi, Hyderabad, Bengaluru, Pune, Ahmedabad, and Chennai.
For orders or assistance, contact us at:
📧 info@globalraremeds.com
📞 +91-99675 15602
📱 WhatsApp: +91-99675 15602
What is the generic name of Zolinza?
Vorinostat is the generic name for the brand Zolinza.
Who manufactures Zolinza?
It is manufactured by Merck & Co., Inc.
What is Zolinza used for?
Zolinza is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in patients with persistent, progressive, or recurrent disease after two prior systemic therapies.
Is Zolinza FDA approved?
Yes, it was approved by the U.S. FDA on October 6, 2006.
What form and strength is Zolinza available in?
Zolinza is available as 100 mg oral capsules.
What documents are required to import Zolinza in India?
Prescription from a licensed oncologist, diagnostic reports, and a valid government-issued ID.
How is Zolinza stored?
Store at room temperature (20°C–25°C). Protect from moisture and keep in the original container.
Can I buy Zolinza online in India?
Yes, Zolinza can be imported legally through GlobalRareMeds with the necessary documentation and medical prescription.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
